The Challenge of the Unacceptable High Mortality in End-Stage Kidney Disease: Is Folic Acid the Answer?

Publisher： Karger

E-ISSN： 1421-9735|24|4|377-378

ISSN： 0253-5068

Source： Blood Purification, Vol.24, Iss.4, 2006-08, pp. : 377-378

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Plasma Homocysteine, Vitamin B₆, Vitamin B₁₂ and Folic Acid in End-Stage Renal Disease during Low-Dose Supplementation with Folic Acid

American Journal of Nephrology, Vol. 18, Iss. 5, 1998-09 ,pp. : 367-372

Karger

Access to resources Recommend Favorite

Electrolyte and Acid-Base Disorders in Chronic Kidney Disease and End-Stage Kidney Failure

Blood Purification, Vol. 43, Iss. 1-3, 2017-01 ,pp. : 179-188

Karger

Access to resources Recommend Favorite

Dyslipidemia in Patients with Chronic and End-Stage Kidney Disease

Cardiorenal Medicine, Vol. 3, Iss. 3, 2013-07 ,pp. : 165-177

Karger

Access to resources Recommend Favorite

Cardiorenal Syndrome in End-Stage Kidney Disease

Blood Purification, Vol. 40, Iss. 4, 2015-0 ,pp. : 337-343

Karger

Access to resources Recommend Favorite

Familial Aggregation of End-Stage Kidney Disease in Brazil

Nephron, Vol. 91, Iss. 4, 2002-07 ,pp. : 666-670

Karger

Access to resources Recommend Favorite